In the early days of COVID-19 vaccine development, a new social media platform provided a place for like-minded people to discuss vaccines, share misinformation and speculate about the motivations for its development. A new study from the University of Kansas shows people flocked to Parler to discuss the vaccines in an echo chamber-type environment, and those conversations can shed light about how to communicate about vaccine efficacy during health crises.